http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1382916-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C13-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-66
filingDate 1972-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1382916-A
titleOfInvention Derivatives of 3-2-1-piperazinyl-ethyl- indoline
abstract 1382916 3-(2-Piperazinoethyl)-indoline derivatives AMERICAN CYANAMID CO 3 May 1972 [27 May 1971] 20674/72 Heading C2C The invention comprises compounds of formula and their pharmacologically acceptable acid addition and quaternary ammonium salts, wherein R 1 is H, Cl, Br, C 1-4 alkoxy, NO 2 , NH 2 , MeCOHN or Me 2 N, and R 2 is H, C 1-4 alkoxy or NO 2 (or R 1 -R 2 may be -OCH 2 O-); R 3 and R 4 are each H or Me; and R 5 is H, Cl, MeO, Me or CF 3 . These compounds are prepared by (1) reducing the corresponding indole; (2) reacting a corresponding 1 - acyl - 3 - XCH 2 CH 2 - indo- line (where X is Cl, Br, MeSO 3 or p-TsO) with a 4-phenylpiperazine, and removing by hydrolysis the 1-acyl groups from the 1-acyl derivative of I thus formed. Also prepared is an intermediate of Formula I where R 1 = MeO, R 2 = NH 2 , R 3 = Me and R 4 = R 5 = H.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0010398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4411900-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4382934-A
priorityDate 1971-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82510178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414939035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430717672

Total number of triples: 40.